Vycor Medical (VYCO) Profit After Tax (2010 - 2026)
Vycor Medical's (VYCO) quarterly Profit After Tax came in at $20108.0 in Q1 2026, up 152.14% year-on-year from $7974.8 in Q1 2025, and up 133.26% on a QoQ basis from -$60450.0 in Q4 2025.
Vycor Medical (VYCO) Profit After Tax (2010 - 2026) Analysis & Trends
Vycor Medical (VYCO) has 17 years of Profit After Tax data on file, last reported at $20108.0 in Q1 2026.
- On a quarterly basis, Profit After Tax rose 152.14% year-over-year to $20108.0 in Q1 2026; TTM through Mar 2026 was -$11519.0, a 90.01% increase from a year earlier, with the FY2025 full-year figure at -$70190.0, up 34.52% from the prior year.
- Profit After Tax for Q1 2026 stood at $20108.0, up from -$60450.0 in the prior quarter.
- Over the last five years, Profit After Tax for VYCO reached as high as $68408.0 in Q2 2023 and fell as low as -$116549.0 in Q4 2022.
- Historically, Profit After Tax has averaged -$37277.4 across 5 years, with a median of -$38563.0 in 2025.
- Across the five-year window, Profit After Tax plunged 10599.58% in 2022 and jumped 337.97% in 2025, its largest moves.
- Year by year, Profit After Tax stood at -$116549.0 in 2022, then grew by 17.14% to -$96570.0 in 2023, then jumped by 92.82% to -$6934.0 in 2024, then plunged by 771.79% to -$60450.0 in 2025, then surged by 133.26% to $20108.0 in 2026.
- Per Business Quant data, the three most recent Profit After Tax figures were $20108.0 in Q1 2026, -$60450.0 in Q4 2025, and $4936.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.39 Bn | 174.10 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 128.38 Bn | 125.50 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 107.68 Bn | 98.46 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 67.98 Bn | 66.53 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 47.81 Bn | 44.13 Bn | 1.29 Bn | 380.70 Mn |
| 6 | GE HealthCare Technologies | 28.53 Bn | 26.25 Bn | 1.98 Bn | 411.00 Mn |
| 7 | Dexcom | 28.35 Bn | 27.24 Bn | 750.30 Mn | 199.50 Mn |
| 8 | Smith & Nephew | 26.78 Bn | 26.20 Bn | - | - |
| 9 | Koninklijke Philips | 25.34 Bn | 22.21 Bn | 2.07 Bn | 170.93 Mn |
| 10 | Vycor Medical | 2.34 Mn | 2.16 Mn | 375,153.00 | 20,108.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20,108.00 |
| Dec 31, 2025 | -60,450.00 |
| Sep 30, 2025 | 4,936.00 |
| Jun 30, 2025 | 23,887.00 |
| Mar 31, 2025 | -38,563.00 |
| Dec 31, 2024 | -6,934.00 |
| Sep 30, 2024 | -59,817.00 |
| Jun 30, 2024 | -10,038.00 |
| Mar 31, 2024 | -30,608.00 |
| Dec 31, 2023 | -96,570.00 |
| Sep 30, 2023 | -51,479.00 |
| Jun 30, 2023 | 68,408.00 |
| Mar 31, 2023 | 7,569.00 |
| Dec 31, 2022 | -116,549.00 |
| Sep 30, 2022 | -114,807.00 |
| Jun 30, 2022 | -99,011.00 |
| Mar 31, 2022 | -73,797.00 |
| Dec 31, 2021 | -159,655.00 |
| Sep 30, 2021 | 7,659.00 |
| Jun 30, 2021 | 943.00 |